Rapinesi Chiara, Bersani Francesco Saverio, Kotzalidis Georgios D, Imperatori Claudio, Del Casale Antonio, Di Pietro Simone, Ferri Vittoria R, Serata Daniele, Raccah Ruggero N, Zangen Abraham, Angeletti Gloria, Girardi Paolo
Department of Neurosciences, Mental Health, and Sensory Organs NESMOS, School of Medicine and Psychology, Sant'Andrea Hospital, Sapienza University of Rome , Rome , Italy ; Neuropsychiatric Unit, Villa Rosa, Suore Ospedaliere of the Sacred Heart of Jesus , Viterbo , Italy.
Department of Neurology and Psychiatry, Policlinico Umberto I University Hospital, Sapienza University of Rome , Rome , Italy.
Front Neurol. 2015 Feb 9;6:16. doi: 10.3389/fneur.2015.00016. eCollection 2015.
Deep transcranial magnetic stimulation (dTMS) is a new form of TMS allowing safe stimulation of deep brain regions. The objective of this preliminary study was to assess the role of dTMS maintenance sessions in protecting patients with bipolar disorder (BD) or recurrent major depressive disorder (MDD) from developing depressive or manic relapses in a 12-month follow-up period.
Twenty-four drug-resistant patients with a current depressive episode and a diagnosis of MDD or BD have been enrolled in the study. All the participants underwent daily dTMS sessions for 4 weeks. One group (maintenance - M group) received additional maintenance dTMS sessions weekly or twice a week.
After the first dTMS cycle, a significant reduction of Hamilton Depression Rating Scale (HDRS) scores was observed in all participants. Subsequently, the HDRS mean scores did not significantly change over time in the M group, while it significantly increased in the non-M-group after 6 and 12 months.
This study confirms previous evidence of a positive therapeutic effect of dTMS on depressive symptoms and suggests that, after recovery from acute episodes, maintenance dTMS sessions may be helpful in maintaining euthymia in a 12-month follow-up period.
深部经颅磁刺激(dTMS)是经颅磁刺激的一种新形式,可安全刺激深部脑区。这项初步研究的目的是评估在12个月的随访期内,dTMS维持治疗对双相情感障碍(BD)或复发性重度抑郁症(MDD)患者预防抑郁或躁狂复发的作用。
本研究纳入了24例目前处于抑郁发作期且诊断为MDD或BD的耐药患者。所有参与者每天接受dTMS治疗,持续4周。一组(维持治疗组-M组)每周或每周两次接受额外的dTMS维持治疗。
在第一个dTMS周期后,所有参与者的汉密尔顿抑郁量表(HDRS)评分均显著降低。随后,M组的HDRS平均评分随时间无显著变化,而非M组在6个月和12个月后显著升高。
本研究证实了先前关于dTMS对抑郁症状具有积极治疗效果的证据,并表明在急性发作恢复后,dTMS维持治疗可能有助于在12个月的随访期内维持心境正常。